Allison et al. conducted studies on cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and developed a cancer treatment strategy based on CTLA-4 blockade with anti-CTLA-4 antibodies [8]. The gene discussed is CTLA4; the disease is cancer.